Assembly Biosciences, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Assembly Biosciences, Inc. on August 5, 2019. The report serves to announce the company's financial results for the quarter ended June 30, 2019. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol ASMB.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notification that these results were issued via a press release attached as Exhibit 99.1, but the specific financial data points are not contained within the body of this 8-K form.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It references the attached press release for the full announcement of the quarter's results.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The text explicitly states that the information furnished, including the attached press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated August 5, 2019) for actual revenue, net loss, and cash position figures.
- Verify the specific details of the quarter ended June 30, 2019, as they are not listed in the 8-K text itself.
- Check subsequent filings (such as the 10-Q) for audited or reviewed financial statements and detailed risk disclosures.
- Confirm the company's status as an emerging growth company and any related accounting standard elections.